Add BrightSurf on Google Email

UT Southwestern Medical Center


Study finds no reason for cancer survivors to be excluded in advanced stage lung cancer trials

A recent study by UT Southwestern Medical Center found that patients with a prior cancer diagnosis have similar clinical outcomes to those without a history of cancer. The researchers studied over 102,000 patients and found that these patients had better overall survival and lung cancer-specific survival rates.

SourceUT Southwestern Medical Center·JournalJNCI Journal of the National Cancer Institute·DateFeb 9, 2015

Long-term use of ventricular assist devices induces heart muscle regeneration, study finds

A study by UT Southwestern Medical Center investigators found that patients with heart failure who used left ventricular assist devices (LVADs) for six months or longer showed significant regeneration of heart muscle. Oxidative damage to a cell-regulator mechanism was prevented, leading to an increase in cardiomyocyte proliferation.

SourceUT Southwestern Medical Center·JournalJournal of the American College of Cardiology·DateJan 21, 2015

Researchers confirm whole-genome sequencing can successfully identify cancer-related mutations

A recent study by UT Southwestern Medical Center researchers confirms that whole-genome sequencing can successfully identify cancer-related mutations in patients. The method was used to analyze the genomes of 258 cancer patients, detecting nearly 90% of clinically identified mutations and discovering additional cancer gene mutations.

SourceUT Southwestern Medical Center·JournalEBioMedicine·DateDec 23, 2014

Signaling mechanism could be target for survival, growth of tumor cells in brain cancer

UT Southwestern Medical Center researchers have identified a cell signaling mechanism that plays a crucial role in brain cancer growth and may provide a new therapeutic target. Non-canonical epidermal growth factor receptor (EGFR) signaling is highly active in glioblastomas, making tumor cells more resistant to chemotherapy treatment.

SourceUT Southwestern Medical Center·JournalNature Communications·DateDec 15, 2014

Study identifying cell of origin for large, disfiguring nerve tumors lays groundwork for development

Researchers at UT Southwestern Medical Center have identified the specific type of cell that gives rise to large, disfiguring plexiform neurofibromas, a finding that could lead to new therapies for preventing tumor growth. The study suggests ways to develop treatments by understanding the steps leading to tumor development.

SourceUT Southwestern Medical Center·JournalCancer Cell·DateNov 11, 2014

Cancer-fighting cocktail demonstrates promising results as treatment for advanced cervical cancer

A combination of chemotherapy drugs cisplatin and pemetrexed improved survival rates and response to advanced cervical cancer by 31% compared to standard alternative, while being less toxic to patients. Adding bevacizumab further increased patient survival, suggesting the cocktail may offer further benefits.

SourceUT Southwestern Medical Center·JournalJournal of Clinical Oncology·DateSep 15, 2014

UT Southwestern expert co-chairs national team to develop first comprehensive guidelines for management of sickle cell disease

A nationwide team of experts led by UT Southwestern hematologist Dr. George Buchanan developed the first comprehensive, evidence-based guidelines for managing sickle cell disease from birth to end of life. The guidelines consist of over 500 specific directions for physicians caring for patients with sickle cell disease.